{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T04:49:05Z","timestamp":1778734145271,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["15Emk0101001h0015"],"award-info":[{"award-number":["15Emk0101001h0015"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.bbr.2020.112802","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T18:38:49Z","timestamp":1594319929000},"page":"112802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Enhancement of the rewarding effects of 3,4-methylenedioxymethamphetamine in orexin knockout mice"],"prefix":"10.1016","volume":"396","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7751-0231","authenticated-orcid":false,"given":"Tomohisa","family":"Mori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Uzawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Masukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8293-2236","authenticated-orcid":false,"given":"Shigeto","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Iwase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayuna","family":"Hokazono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Udagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2020.112802_bib0005","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.smrv.2004.03.002","article-title":"Pharmacotherapy for excessive daytime sleepiness","volume":"8","author":"Banerjee","year":"2004","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.bbr.2020.112802_bib0010","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0006-8993(83)91101-0","article-title":"Activity of mesencephalic dopamine and non-dopamine neurons across stages of sleep and waking in the rat","volume":"273","author":"Miller","year":"1983","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2020.112802_bib0015","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/0024-3205(93)90592-Q","article-title":"Involvement of histamine in the control of the waking state","volume":"53","author":"Monti","year":"1992","journal-title":"Life Sci."},{"key":"10.1016\/j.bbr.2020.112802_bib0020","series-title":"Principles and Practice of Sleep Medicine","first-page":"134","article-title":"Basic mechanisms of sleep\u2013wake states","author":"Jones","year":"2000"},{"key":"10.1016\/j.bbr.2020.112802_bib0025","series-title":"Principles and Practice in Sleep Medicine","first-page":"112","article-title":"Brainstem mechanisms generating REM sleep","author":"Siegel","year":"2000"},{"key":"10.1016\/j.bbr.2020.112802_bib0030","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1212\/WNL.50.2_Suppl_1.S16","article-title":"Genetic and familial aspects of narcolepsy","volume":"50","author":"Mignot","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2020.112802_bib0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","article-title":"Hypocretin (orexin) deficiency in human narcolepsy","volume":"355","author":"Nishino","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.bbr.2020.112802_bib0040","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/79690","article-title":"A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains","volume":"6","author":"Peyron","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbr.2020.112802_bib0045","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0896-6273(00)00058-1","article-title":"Reduced number of hypocretin neurons in human narcolepsy","volume":"27","author":"Thannickal","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.bbr.2020.112802_bib0050","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1073\/pnas.96.2.748","article-title":"Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems","volume":"96","author":"Date","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbr.2020.112802_bib0055","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0006-8993(99)01336-0","article-title":"Distribution of orexin neurons in the adult rat brain","volume":"827","author":"Nambu","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2020.112802_bib0060","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.bcp.2007.08.003","article-title":"Monoamine transporters and psychostimulant addiction","volume":"75","author":"Howell","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbr.2020.112802_bib0065","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1523\/JNEUROSCI.2761-05.2006","article-title":"Direct involvement of orexinergic system in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine","volume":"26","author":"Narita","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2020.112802_bib0070","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.neuropharm.2009.08.009","article-title":"Monoaminergic neuronal changes in orexin deficient mice","volume":"58","author":"Mori","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2020.112802_bib0075","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1007\/s00213-016-4282-1","volume":"233","author":"Mori","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2020.112802_bib0080","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.neuron.2006.01.016","article-title":"Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine","volume":"49","author":"Borgland","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.bbr.2020.112802_bib0085","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nm0306-274","article-title":"Orexin: a gatekeeper of addiction","volume":"12","author":"Carr","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbr.2020.112802_bib0090","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00213-010-2048-8","article-title":"Hypocretin 1\/orexin A in the ventral tegmental area enhances dopamine responses to cocaine and promotes cocaine self-administration","volume":"214","author":"Espa\u00f1a","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2020.112802_bib0095","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/npp.2017.158","article-title":"Effects of suvorexant, a dual orexin\/hypocretin receptor antagonist, on impulsive behavior associated with cocaine","volume":"43","author":"Gentile","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2020.112802_bib0100","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0092-8674(00)81973-X","article-title":"Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation","volume":"98","author":"Chemelli","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.bbr.2020.112802_bib0105","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0014-2999(91)90774-K","article-title":"Pertussis toxin abolishes mu- and delta-opioid agonist-induced place preference","volume":"205","author":"Suzuki","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2020.112802_bib0110","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1124\/jpet.114.214288","article-title":"Differential substitution for the discriminative stimulus effects of 3,4-methylenedioxymethamphetamine and methylphenidate in rats","volume":"350","author":"Mori","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbr.2020.112802_bib0115","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ejphar.2013.07.046","article-title":"Comparison of the behavioral effects of bupropion and psychostimulants","volume":"718","author":"Mori","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2020.112802_bib0120","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejphar.2007.06.062","article-title":"Lack of development of behavioral sensitization to methylphenidate in mice: correlation with reversible astrocytic activation","volume":"574","author":"Suzuki","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2020.112802_bib0125","doi-asserted-by":"crossref","first-page":"15409","DOI":"10.1074\/jbc.M009716200","article-title":"Enhanced mu- opioid responses in the spinal cord of mice lacing protein kinase Cgamma isoform","volume":"276","author":"Narita","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2020.112802_bib0130","series-title":"Paxinos and Franklin\u2019s the Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2013"},{"key":"10.1016\/j.bbr.2020.112802_bib0135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuint.2009.08.012","article-title":"The orexin-1 receptor antagonist SB-334867 reduces amphetamine-evoked dopamine outflow in the shell of the nucleus accumbens and decreases the expression of amphetamine sensitization","volume":"56","author":"Quarta","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbr.2020.112802_bib0140","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neuropharm.2009.07.008","article-title":"Orexin receptor antagonism prevents transcriptional and behavioral plasticity resulting from stimulant exposure","volume":"58","author":"Winrow","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2020.112802_bib0145","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1523\/JNEUROSCI.4561-11.2012","article-title":"A septal-hypothalamic pathway drives orexin neurons, which is necessary for conditioned cocaine preference","volume":"32","author":"Sator","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2020.112802_bib0150","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1460-9568.2009.07065.x","article-title":"The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system","volume":"31","author":"Espa\u00f1a","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbr.2020.112802_bib0155","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00213-005-0255-5","article-title":"Relevance of rodent models of intravenous MDMA self-administration to human MDMA consumption patterns","volume":"189","author":"De La Garza","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2020.112802_bib0160","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00213-011-2241-4","article-title":"Rats preexposed to MDMA display attenuated responses to its aversive effects in the absence of persistent monoamine depletions","volume":"216","author":"Albaugh","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2020.112802_bib0165","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1038\/sj.npp.1301309","article-title":"Rewarding effects and reinstatement of MDMA-induced CPP in adolescent mice","volume":"32","author":"Daza-Losada","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2020.112802_bib0170","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.niox.2020.03.001","article-title":"Blockade of nitric oxide signalling promotes resilience to the effects of social defeat stress on the conditioned rewarding properties of MDMA in mice","volume":"98","author":"Garc\u00eda-Pardo","year":"2020","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.bbr.2020.112802_bib0175","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pbb.2013.11.011","article-title":"A 3-lever discrimination procedure reveals differences in the subjective effects of low and high doses of MDMA","volume":"116","author":"Harper","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2020.112802_bib0180","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/sj.bjp.0705506","article-title":"Importance of ERK activation in behavioral and biochemical effects induced by MDMA in mice","volume":"140","author":"Salzmann","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbr.2020.112802_bib0185","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0026-895X(25)09516-1","article-title":"4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]ketanserin labeling of 5-hydroxytryptamine2 (5HT2) receptors in mammalian cells transfected with a rat 5HT2 cDNA: evidence for multiple states and not multiple 5HT2 receptor subtypes","volume":"38","author":"Teitler","year":"1990","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbr.2020.112802_bib0190","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/sj.bjp.0703855","article-title":"Regulation of 5-HT(1A) receptor-stimulated [35S]-GtpgammaS binding as measured by quantitative autoradiography following chronic agonist administration","volume":"132","author":"Hensler","year":"2001","journal-title":"Br. J. Pharmacol."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432820305015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432820305015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:26:33Z","timestamp":1759065993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432820305015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":38,"alternative-id":["S0166432820305015"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2020.112802","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancement of the rewarding effects of 3,4-methylenedioxymethamphetamine in orexin knockout mice","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2020.112802","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112802"}}